Post lung-transplant recipients with worsening depression: the need to identify, refer, and treat, but does it really help?

Sarah Andrews
DOI: https://doi.org/10.1136/thoraxjnl-2022-218839
2022-08-18
Thorax
Abstract:All lung transplant patients must undergo a psychosocial evaluation during the transplant process, which is vital in appreciating patients' strengths, as well as any potential risk factors. Screening for psychiatric disorders is not used as an absolute exclusion measure, but rather a means to identify and better manage patients who may benefit from additional resources during the pretransplant and post-transplant periods.1 2 Depression, a treatable condition, can range from mild to severe with different interventions available.3 Given that the transplant process can be stressful for patients, screening for depression and subsequently treating even mild depression is vital for transplant patients. Screening must occur not only pretransplant, but also post transplant since depression can negatively impact patients throughout the transplant process, particularly post transplant.4 The majority of research has focused on depression as a single time point, while Kolaitis et al
respiratory system
What problem does this paper attempt to address?